Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (7055)	2/22/1999 9:46:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

The Big Pharma Report: 2/21/99 Have PFun! BigKNY3 ________________________________________________________ Big Pharma Scoreboard 2/21/99 -MRK (+5.0%) made a strong move up post-split. -WLA (-7.4%) is still suffering Rezulin blues. -PFE continues to circle around 130. . Price % Chg % Chg % Chg Rank . 02/21/99 Week Feb YTD 1999 1 Amgen 124.13 3.2% -2.9% 18.7% 2 Merck 79.00 5.0% 7.7% 7.1% 3 Lilly 93.06 3.2% -0.7% 4.7% 4 Amer 58.31 -0.1% -0.6% 3.4% 5 J&J 86.63 2.4% 1.8% 3.3% 6 Pfizer 128.31 -1.4% -0.2% 2.7% 7 Smith 68.88 1.1% 1.6% -0.9% 8 Scher 52.81 -4.0% -3.1% -4.4% 9 Bristol 125.88 0.3% -1.9% -5.9% 10 Pharma 53.25 -2.3% -7.4% -6.0% 11 Abbott 46.00 2.2% -0.9% -6.1% 12 Glaxo 64.31 0.8% -5.2% -7.5% 13 Warner 63.88 -7.4% -11.7% -15.0% Big Pharma 80.34 0.5% -1.7% 0.3% Dow 9,340 0.7% -0.2% 1.7% S&P 500 1,239 0.7% -3.2% 0.8% NASDAQ 2,283 -1.6% -8.9% 4.1% News/chart/quote links to Big Pharma and ED stocks: Yahoo! PFE News biz.yahoo.com Five Day Chart of PFE versus the Dow quicken.com A great PFE Stat Website dailystocks.com Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com Free Merrill Lynch Research Reports Weekly reports highlight Trovan, Lipitor and Viagra preceription action askmerrill.com A New Investment Website Worth A Try bridge.com Big Pharma Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com ED Stocks Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com The 1999 Pharma Portfolio Challenge: Motley Fool /SI Challenge Highlights -Ron Flanagan (+9.4%) remains #1 with an equal trifecta of PFE/MRK/AMGN (Portfolio: 33% PFE/MRK/AMGN, 1% Cash). -The 1998 PFEr of the Year Sinbadnaz (+8.9%) has moved up to second place (Portfolio: 50% MRK; 25% PFE/AMGN) -Prankster DRUG STOCK (-6.0%) is off to a PnU start. (Portfolio: 100% PNU)